Otros idiomas Immunovia AB

Acciones

IMMNOV

SE0006091997

Equipo médico y tecnología avanzada

Mercado cerrado - Nasdaq Stockholm Otros sitios de cotización 18:00:00 13/06/2025			Variación 5 días	Varia. 1 de enero.
0,4285 ^SEK	-2,39 %		-11,74 %	-21,52 %

09/06	El estudio de desarrollo del modelo de Immunovia publicado en la revista	FW
04/06	Immunovia llevará a cabo un nuevo estudio de validación clínica de la prueba Pancreasure.	FW

Otros idiomas

Immunovia : Model Development Study Published in Cancers	09/06
Immunovia’s Model Development Study Published in Cancers	09/06
Immunovia : Leiden University to study Immunovia's PancreaSure test in group at unusually high risk for pancreatic cancer	04/06
Leiden University to study Immunovia’s PancreaSure test in group at unusually high risk for pancreatic cancer	04/06
Immunovia Announces New Clinical Validation Study in Partnership with Leiden University Medical Center	04/06
Immunovia Selected for Presentation at EDRN Scientific Workshop in US on May 21	21/05
Research update Immunovia: All eyes on securing the launch of PancreaSure	15/05
BULLETIN FROM THE ANNUAL GENERAL MEETING ON 14 MAY 2025 IN IMMUNOVIA AB (PUBL)	14/05
Immunovia AB Approves Board Changes	14/05
Immunovia : Invitation to Immunovia's Q1 presentation	14/05
Invitation to Immunovia’s Q1 presentation	14/05
Immunovia Publishes Interim Report for January-March 2025	14/05
Immunovia AB Reports Earnings Results for the First Quarter Ended March 31, 2025	14/05
CLARITI Study Featured in Best of Digestive Disease Week	07/05
Immunovia AB Announces Clinical Validation Study Results in Digestive Disease Week	07/05
Immunovia : PancreaSure, Immunovia's Next-Generation Test for Early Detection of Pancreatic Cancer	05/05
PancreaSure, Immunovia’s Next-Generation Test for Early Detection of Pancreatic Cancer	05/05
Immunovia : Change in number of shares and votes in Immunovia AB (publ)	30/04
Immunovia AB announces outcome of exercise of warrants series TO 3	17/04
Immunovia : to present at Aktiespararna's Life Science event on April 23	17/04
Immunovia to present at Aktiespararna’s Life Science event on April 23	17/04
NOTICE OF ANNUAL GENERAL MEETING IN IMMUNOVIA AB (PUBL)	14/04
Last day of trading in warrants series TO 3 in Immunovia	11/04
Immunovia : CEO and board members announce intention to fully exercise their TO 3 warrants	10/04
Immunovia’s CEO and board members announce intention to fully exercise their TO 3 warrants	10/04

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Immunovia AB

Acciones

IMMNOV

SE0006091997

Equipo médico y tecnología avanzada

Otros idiomas

Filtros